13F-HR filed by BVF INC/IL
BVF INC/IL filed this 13F-HR for the quarter ended 2014-09-30, filed 2014-11-14, with 32 holding rows worth $481,628,000.
- Accession
- 0000921895-14-002431
- Filer
- CIK 1056807
- Filed
- 2014-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2014
A holdings report, 32 entries on the cover page, a total value of $481,628,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $481,628,000 with VALUE read as thousands by filing date, 13F file number 028-06800. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerBVF PARTNERS L P/IL028-06770
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 5,597,065 | $72,510,000 | thousands by filing date | |
| RECEPTOS, INC. | 756207106 | COMMON STOCK | 1,146,300 | $71,197,000 | thousands by filing date | |
| LIGAND PHARMACEUTICALS INC | 53220K504 | COM NEW | 1,108,763 | $52,101,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 13,876,513 | $49,539,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 8,596,772 | $38,685,000 | thousands by filing date | |
| ONCOMED PHARMACEUTICALS INC COM | 68234X102 | Stock | 1,287,847 | $24,379,000 | thousands by filing date | |
| ONCOTHYREON INC | 682324108 | COM | 9,867,278 | $18,945,000 | thousands by filing date | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 1,461,900 | $17,148,000 | thousands by filing date | |
| TARGACEPT INC | 87611R306 | COM | 6,655,128 | $16,837,000 | thousands by filing date | |
| LOXO ONCOLOGY INC | 548862101 | COM | 1,192,202 | $15,654,000 | thousands by filing date | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 1,206,459 | $15,213,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC | 04269XAA3 | NOTE 3.000% 6/0 | 16,000,000 | $14,400,000 | thousands by filing date | principal |
| EXELIXIS INC | 30161QAC8 | NOTE 4.250% 8/1 | 17,175,000 | $10,012,000 | thousands by filing date | principal |
| QLT INC | 746927102 | COMMON STOCK | 2,093,563 | $9,463,000 | thousands by filing date | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 549,000 | $9,437,000 | thousands by filing date | |
| TREVENA INC | 89532E109 | COM | 1,118,743 | $7,182,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 453,541 | $6,445,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 1,527,000 | $5,375,000 | thousands by filing date | |
| VITAE PHARMACEUTICALS INC | 92847N103 | COM | 666,000 | $5,082,000 | thousands by filing date | |
| ARQULE INC | 04269E107 | COM | 4,300,887 | $4,817,000 | thousands by filing date | |
| REGADO BIOSCIENCE INC | 75874Q107 | COM | 2,607,091 | $2,946,000 | thousands by filing date | |
| BIOLINERX LTD-SPONS ADR | 09071M106 | SPON | 1,501,000 | $2,312,000 | thousands by filing date | |
| KALOBIOS PHARMACEUTICALS INC | 48344T100 | COM | 1,162,000 | $1,801,000 | thousands by filing date | |
| ONCOGENEX PHARMACEUTICALS IN | 68230A106 | COM | 662,069 | $1,768,000 | thousands by filing date | |
| SOPHIRIS BIO INC F | 83578Q209 | FOREIGN CANADIAN | 600,000 | $1,758,000 | thousands by filing date | |
| REGULUS THERAPEUTICS INC | 75915K101 | COM | 184,999 | $1,264,000 | thousands by filing date | |
| ACHAOGEN INC | 004449104 | COM | 136,600 | $1,224,000 | thousands by filing date | |
| BIOTA PHARMACEUTIALS INC | 090694100 | COM | 435,900 | $1,077,000 | thousands by filing date | |
| ANTHERA PHARMACEUTCLS INC | 03674U201 | Common equity shares | 559,624 | $1,074,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 106,500 | $981,000 | thousands by filing date | |
| PALATIN TECHNOLOGIES INC | 696077403 | COM PAR $ .01 | 750,655 | $698,000 | thousands by filing date | |
| TRANSCEPT PHARMACEUTICALS IN | 89354M106 | COM | 150,000 | $304,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000921895-14-002431 | this filing | 2014-11-14 | acceptance time not in the bulk data set |